Clinical Research Directory
Browse clinical research sites, groups, and studies.
Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease
Sponsor: University of California, San Francisco
Summary
Central nervous system (CNS) metastases including breast cancer brain metastases (BCBMs) and leptomeningeal disease (LMD) are common affecting up to 30% of patients with metastatic breast cancer (MBC). The goal of this research is to understand symptom burden and quality of life trajectories in this population and how treatments guide care management decisions.
Official title: Prospective Evaluation of Quality of Life in Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2026-10-15
Completion Date
2035-12-31
Last Updated
2026-08-24
Healthy Volunteers
No
Conditions
Interventions
Health-Related Quality of Life (QOL) questionnaires
Participants can complete questionnaires online, via tablet in clinic, or via paper and pencil in clinic
Medical Chart Review
Data will be collected from the participants electronic medical record
Locations (1)
University of California, San Francisco
San Francisco, California, United States